0,862  0,004  Free radical scavenger
0,835  0,004  UDP-glucuronosyltransferase substrate
0,836  0,004  Antioxidant
0,824  0,004  Aldehyde oxidase inhibitor
0,819  0,004  Cardiovascular analeptic
0,799  0,004  Amyloid beta aggregation inhibitor
0,796  0,005  GST A substrate
0,752  0,002  Peroxidase inhibitor
0,743  0,004  AR expression inhibitor
0,711  0,004  Skin whitener
0,732  0,025  Apoptosis agonist
0,708  0,005  UGT1A6 substrate
0,704  0,003  Alcohol oxidase inhibitor
0,706  0,006  CTGF expression inhibitor
0,696  0,007  UGT1A9 substrate
0,711  0,023  Caspase 9 stimulant
0,667  0,005  Antimutagenic
0,663  0,003  HIV-1 integrase (3'-Processing) inhibitor
0,663  0,004  Antiseptic
0,645  0,004  GABA C receptor rho-3 antagonist
0,640  0,005  Superoxide dismutase inhibitor
0,641  0,011  5 Hydroxytryptamine release stimulant
0,634  0,004  FMO1 substrate
0,626  0,008  Cardioprotectant
0,605  0,005  Topoisomerase II inhibitor
0,603  0,003  Tyrosine 3 hydroxylase inhibitor
0,596  0,004  Lipid peroxidase inhibitor
0,594  0,003  SULT1A3 substrate
0,626  0,047  Antiinflammatory
0,582  0,003  Pneumotoxic
0,570  0,005  Mcl-1 antagonist
0,564  0,004  Chelator
0,572  0,012  Caspase 3 stimulant
0,561  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,562  0,006  Genotoxic
0,555  0,003  Carcinogenic, group 1
0,578  0,029  TNF expression inhibitor
0,559  0,013  Ulceration
0,550  0,004  GST P1-1 substrate
0,570  0,024  CYP2C9 substrate
0,542  0,003  Cystathionine beta-synthase inhibitor
0,551  0,014  Apoptosis antagonist
0,540  0,004  GST M1-1 substrate
0,539  0,004  5 Hydroxytryptamine uptake stimulant
0,537  0,005  Sulfotransferase substrate
0,551  0,020  CYP2C19 substrate
0,550  0,019  5 Hydroxytryptamine release inhibitor
0,555  0,026  Antiparkinsonian
0,532  0,003  HIV-1 integrase (Strand Transfer) inhibitor
0,543  0,018  Histamine release inhibitor
0,554  0,031  15-Lipoxygenase inhibitor
0,540  0,019  CYP1A2 substrate
0,522  0,008  UGT2B4 substrate
0,509  0,004  Glutathione S-transferase substrate
0,513  0,010  Antihypertriglyceridemic
0,505  0,007  Flavin-containing monooxygenase substrate
0,526  0,028  Cholesterol antagonist
0,501  0,004  GABA C receptor agonist
0,523  0,026  Antipruritic, allergic
0,501  0,005  FMO3 substrate
0,504  0,009  Antihypoxic
0,512  0,021  Analeptic
0,490  0,004  Alpha tubulin antagonist
0,490  0,008  UGT1A3 substrate
0,484  0,005  NOS3 expression enhancer
0,498  0,020  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,506  0,028  Respiratory analeptic
0,498  0,022  Chemoprotective
0,478  0,005  UGT2B15 substrate
0,493  0,022  12-Lipoxygenase inhibitor
0,494  0,023  Radioprotector
0,493  0,024  Carcinogenic
0,473  0,005  5-Lipoxygenase inhibitor
0,470  0,004  Porphobilinogen synthase inhibitor
0,476  0,011  UGT1A1 substrate
0,471  0,022  NOS2 expression inhibitor
0,484  0,034  Calcium channel L-type activator
0,457  0,009  Tubulin antagonist
0,482  0,035  Prostate cancer treatment
0,457  0,010  UGT1A4 substrate
0,500  0,054  Antineoplastic (breast cancer)
0,451  0,005  DNA polymerase I inhibitor
0,451  0,007  Amylase inhibitor
0,466  0,025  NOS3 expression inhibitor
0,445  0,004  M18 aspartyl aminopeptidase inhibitor
0,481  0,043  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,452  0,015  Antineoplastic (osteosarcoma)
0,440  0,004  Topoisomerase II alpha inhibitor
0,458  0,025  Cytostatic
0,447  0,014  RNA-directed DNA polymerase inhibitor
0,445  0,016  Vascular (periferal) disease treatment
0,431  0,003  Creatine kinase inhibitor
0,438  0,010  Dual specificity phosphatase 3 inhibitor
0,441  0,013  Antineoplastic (small cell lung cancer)
0,476  0,048  Transcription factor NF kappa B inhibitor
0,433  0,005  UGT2B1 substrate
0,442  0,021  Nitric oxide antagonist
0,439  0,017  Radiosensitizer
0,470  0,050  Antineoplastic (lung cancer)
0,424  0,004  Succinate dehydrogenase inhibitor
0,431  0,011  Dual specificity phosphatase inhibitor
0,457  0,038  Stroke treatment
0,443  0,025  Antineoplastic (non-small cell lung cancer)
0,453  0,036  Embryotoxic
0,454  0,037  Teratogen
0,498  0,081  Alpha-glucosidase inhibitor
0,416  0,005  Carcinogenic, group 2B
0,425  0,017  Pyruvate kinase inhibitor
0,408  0,003  Phenylalanine 4-hydroxylase inhibitor
0,414  0,009  Antiviral (Influenza)
0,427  0,023  Hypoglycemic
0,432  0,028  ICAM1 expression inhibitor
0,452  0,050  CYP3A4 substrate
0,431  0,030  Lipoxygenase inhibitor
0,427  0,027  Mutagenic
0,407  0,007  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,430  0,031  Antineoplastic (glioma)
0,434  0,037  CYP2D6 substrate
0,405  0,008  Acaricide
0,428  0,033  Antineoplastic (brain cancer)
0,423  0,029  Sensitization
0,417  0,025  Antineoplastic (glioblastoma multiforme)
0,413  0,021  Vasodilator
0,417  0,025  Antipyretic
0,413  0,021  Antimitotic
0,394  0,004  Beta tubulin antagonist
0,402  0,014  Antiviral (HIV)
0,392  0,004  Carbonic anhydrase III inhibitor
0,388  0,006  Topoisomerase I inhibitor
0,394  0,012  UGT2B7 substrate
0,418  0,037  Antineoplastic (melanoma)
0,426  0,047  Vasodilator, peripheral
0,403  0,024  Calcium channel activator
0,383  0,004  Nitric-oxide synthase stimulant
0,381  0,006  UDP-glucose 4-epimerase inhibitor
0,391  0,017  Anesthetic general
0,386  0,013  Carcinogenic, group 3
0,375  0,003  Glutamate decarboxylase inhibitor
0,386  0,017  Skin irritative effect
0,387  0,021  Antineoplastic (lymphocytic leukemia)
0,391  0,027  Cardiodepressant
0,420  0,058  Antileukemic
0,374  0,014  Melanin inhibitor
0,391  0,032  Hypoxia-inducible factor 1 alpha inhibitor
0,361  0,005  Gout treatment
0,368  0,013  Antipruritic, non-allergic
0,399  0,044  Antineoplastic (ovarian cancer)
0,357  0,003  SULT1A1 substrate
0,358  0,005  Histidine decarboxylase inhibitor
0,362  0,009  Amyloid beta precursor protein antagonist
0,352  0,004  Mannose-6-phosphate isomerase inhibitor
0,393  0,045  Antihypercholesterolemic
0,351  0,005  Estrogen receptor beta antagonist
0,349  0,004  HIV-1 integrase inhibitor
0,378  0,033  Proliferative diseases treatment
0,372  0,027  Angiogenesis stimulant
0,354  0,009  Neurotrophic factor enhancer
0,385  0,040  Aryl hydrocarbon receptor agonist
0,345  0,005  Estrogen antagonist
0,398  0,058  Thioredoxin glutathione reductase inhibitor
0,379  0,040  Antineoplastic (cervical cancer)
0,345  0,006  UGT2B9 substrate
0,368  0,030  Myocardial infarction treatment
0,359  0,022  Antineoplastic (sarcoma)
0,366  0,030  Antiparasitic
0,346  0,011  Antiparkinsonian, tremor relieving
0,406  0,074  Antibacterial
0,361  0,029  Antineoplastic (endocrine cancer)
0,334  0,003  Antihelmintic (Fasciola)
0,349  0,018  Antihypotensive
0,334  0,005  Excitatory amino acid transporter EAAC1 inhibitor
0,353  0,024  Abortion inducer
0,337  0,008  NADPH oxidase inhibitor
0,338  0,009  Antineoplastic (bone cancer)
0,348  0,019  Hepatoprotectant
0,331  0,005  Carbonic anhydrase VI inhibitor
0,379  0,053  Streptokinase A inhibitor
0,363  0,037  DNA damaging
0,330  0,005  Antispirochetal
0,347  0,023  Antihelmintic
0,345  0,021  Platelet adhesion inhibitor
0,347  0,024  Antiparkinsonian, rigidity relieving
0,351  0,029  Interleukin agonist
0,345  0,024  Eye irritation, high
0,351  0,029  Antiulcerative
0,356  0,038  Antiamyloidogenic
0,325  0,007  Aldehyde oxidase substrate
0,321  0,004  UGT2B10 substrate
0,354  0,037  Sodium/bile acid cotransporter inhibitor
0,328  0,012  CYP2B6 inhibitor
0,353  0,037  Tumour necrosis factor alpha release inhibitor
0,331  0,016  Phospholipase C inhibitor
0,349  0,034  Insulysin inhibitor
0,349  0,035  Chemopreventive
0,316  0,004  Triose-phosphate isomerase inhibitor
0,347  0,035  Transcription factor STAT inhibitor
0,382  0,072  CYP2C19 inhibitor
0,313  0,004  Carcinogenic, group 2A
0,324  0,015  Monophenol monooxygenase inhibitor
0,360  0,051  Vasodilator, coronary
0,402  0,094  Alzheimer's disease treatment
0,320  0,014  Antihelmintic (Nematodes)
0,313  0,006  Ferrochelatase inhibitor
0,375  0,069  CYP2C9 inhibitor
0,361  0,056  Hepatic disorders treatment
0,341  0,036  Transcription factor STAT3 inhibitor
0,306  0,002  Antidote, mercury
0,317  0,014  Antiviral (Influenza A)
0,306  0,004  HIV-1 integrase (Overall Integration) inhibitor
0,364  0,061  Antineoplastic (colorectal cancer)
0,396  0,093  Antidiabetic
0,396  0,093  Cyclophilin D inhibitor
0,375  0,074  Prostaglandin dehydrogenase inhibitor
0,339  0,039  Antidiabetic symptomatic
0,319  0,020  DNA methyltransferase I inhibitor
0,301  0,004  Keratolytic
0,315  0,021  VCAM1 expression inhibitor
0,356  0,063  Bone diseases treatment
0,295  0,003  DOPA decarboxylase inhibitor
0,355  0,063  Antithrombotic
0,311  0,020  Antineoplastic (squamous cell carcinoma)
0,332  0,041  Antineoplastic (renal cancer)
0,306  0,015  Antidote
0,298  0,009  Interleukin 4 antagonist
0,298  0,010  Antifungal enhancer
0,312  0,024  DNA methylase inhibitor
0,293  0,005  Arylamine N-Acetyltransferase substrate
0,347  0,062  Antineoplastic (colon cancer)
0,293  0,008  Carbonic anhydrase XV inhibitor
0,288  0,006  GABA C receptor rho-2 antagonist
0,287  0,009  Antihemorrhagic
0,282  0,005  Macrophage migration inhibitory factor inhibitor
0,280  0,004  Antihelmintic (Trematoda)
0,282  0,007  NADH dehydrogenase inhibitor
0,329  0,056  Antiosteoporotic
0,281  0,007  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,278  0,005  Uric acid excretion stimulant
0,308  0,039  Cyclic AMP phosphodiesterase inhibitor
0,293  0,025  Antialcoholic
0,281  0,014  Antiviral (West Nile virus)
0,276  0,009  ATPase inhibitor
0,271  0,005  GABA C receptor antagonist
0,271  0,006  Toll-Like receptor 2 antagonist
0,266  0,003  GST T1-1 substrate
0,329  0,068  Antifungal
0,303  0,042  DNA synthesis inhibitor
0,316  0,056  Antineoplastic (multiple myeloma)
0,282  0,023  Protein-tyrosine phosphatase inhibitor
0,320  0,061  Antineoplastic (pancreatic cancer)
0,313  0,054  CYP1A2 inhibitor
0,307  0,050  Cytotoxic
0,264  0,009  VEGF expression inhibitor
0,278  0,023  Interferon gamma antagonist
0,378  0,125  DNA directed DNA polymerase inhibitor
0,267  0,015  LDLR expression enhancer
0,259  0,008  Carbonic anhydrase XIII inhibitor
0,255  0,005  Aldose reductase inhibitor
0,253  0,003  SULT1A2 substrate
0,256  0,006  Antirickettsial
0,281  0,032  Peptidyltransferase inhibitor
0,253  0,006  Antiprotozoal (Babesia)
0,286  0,040  5 Hydroxytryptamine 1E antagonist
0,255  0,009  Adenylate kinase inhibitor
0,266  0,021  Histone acetyltransferase inhibitor
0,257  0,013  5 Hydroxytryptamine 3E antagonist
0,244  0,004  Adenylate cyclase stimulant
0,256  0,017  Aldehyde dehydrogenase inhibitor
0,251  0,012  Xanthine oxidase inhibitor
0,250  0,013  Expectorant
0,245  0,010  Telomerase inhibitor
0,367  0,132  DNA polymerase beta inhibitor
0,239  0,007  Mucolytic
0,240  0,008  Arachidonic acid antagonist
0,235  0,005  Prolactin inhibitor
0,235  0,007  Estrogen agonist
0,247  0,018  Hexokinase inhibitor
0,266  0,037  Non-steroidal antiinflammatory agent
0,235  0,007  NAT2 substrate
0,286  0,059  Antiprotozoal (Leishmania)
0,236  0,009  Alcohol dehydrogenase inhibitor
0,248  0,020  Alkaline phosphatase inhibitor
0,235  0,009  Selectin antagonist
0,247  0,022  Cyclooxygenase 1 inhibitor
0,230  0,007  Gastritis treatment
0,278  0,057  Antineoplastic (lymphoma)
0,322  0,102  Immunosuppressant
0,220  0,002  Catechol O-methyltransferase inhibitor
0,222  0,005  GABA C receptor rho-1 antagonist
0,244  0,028  Protein kinase stimulant
0,234  0,019  Cell wall synthesis inhibitor
0,245  0,030  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,223  0,010  Coagulant
0,224  0,012  CF transmembrane conductance regulator agonist
0,220  0,009  Phosphofructokinase-1 inhibitor
0,291  0,081  Immunostimulant
0,242  0,034  Antiviral (Herpes)
0,267  0,061  Gastrin inhibitor
0,225  0,020  Death-associated protein kinase 2 inhibitor
0,228  0,024  Antiviral (Ebola)
0,237  0,033  Cytidine deaminase inhibitor
0,233  0,030  CNS active muscle relaxant
0,224  0,022  Cholesterol synthesis inhibitor
0,214  0,014  Movement disorders treatment
0,223  0,022  Antihyperlipoproteinemic
0,224  0,025  Uterine stimulant
0,222  0,022  Phobic disorders treatment
0,201  0,002  Dopamine D5 agonist
0,225  0,026  Antidiarrheal
0,204  0,006  NAT1 substrate
0,222  0,024  Antianemic
0,206  0,009  Antiviral (Influenza B)
0,260  0,063  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,276  0,080  Spasmolytic
0,245  0,051  Wound healing agent
0,198  0,004  UGT2B11 substrate
0,228  0,035  Heat shock protein 90 alpha antagonist
0,236  0,043  Insulin sensitizer
0,196  0,004  Ca2+-transporting ATPase inhibitor
0,205  0,014  5 Hydroxytryptamine 3A agonist
0,204  0,013  Antineoplastic, alkylator
0,197  0,007  Heat shock protein 70 antagonist
0,229  0,040  Thrombolytic
0,194  0,005  Carbonic anhydrase VB inhibitor
0,205  0,017  Cyclooxygenase 3 inhibitor
0,247  0,061  MAP-kinase-activated kinase 5 inhibitor
0,208  0,024  Adenylate cyclase inhibitor
0,197  0,014  Aldehyde dehydrogenase substrate
0,188  0,005  Antifungal (Pneumocystis)
0,215  0,032  Bone formation stimulant
0,186  0,004  D-Ala-D-Ala ligase inhibitor
0,211  0,028  Antiprotozoal (Coccidial)
0,189  0,008  SULT1E1 substrate
0,185  0,003  Granulocyte macrophage colony stimulating factor agonist
0,188  0,008  Vanilloid agonist
0,216  0,036  Skeletal muscle relaxant
0,194  0,014  Sphingosine 1-phosphate receptor 5 antagonist
0,204  0,025  DNA intercalator
0,190  0,011  Glutamate dehydrogenase inhibitor
0,193  0,015  Protein kinase C gamma inhibitor
0,191  0,013  Protein kinase C mu inhibitor
0,186  0,008  Carbonic anhydrase V inhibitor
0,204  0,028  Protein-tyrosine phosphatase 1B inhibitor
0,189  0,013  Chronic obstructive bronchitis treatment
0,183  0,007  Myeloperoxidase inhibitor
0,209  0,034  Heat shock protein 90 antagonist
0,179  0,005  Neuraminidase (influenza) inhibitor
0,206  0,032  Neurotensin receptor agonist
0,218  0,044  Tumour necrosis factor antagonist
0,188  0,015  Vanilloid 1 agonist
0,175  0,004  Antiviral (Parainfluenza)
0,184  0,013  Protein kinase C zeta inhibitor
0,190  0,019  Choleretic
0,182  0,012  NAD(P)H dehydrogenase (quinone) inhibitor
0,295  0,126  Atherosclerosis treatment
0,207  0,038  Neuropathy treatment
0,176  0,009  CDC25A inhibitor
0,189  0,022  Microtubule formation inhibitor
0,232  0,065  Psychostimulant
0,191  0,024  Antibacterial (Helicobacter pylori)
0,208  0,042  Hair growth stimulant
0,170  0,004  Topoisomerase II beta inhibitor
0,211  0,046  3C-like protease (Human coronavirus) inhibitor
0,174  0,009  Carbamoyl phosphate synthetase inhibitor
0,179  0,013  Urease inhibitor
0,180  0,016  Beta glucuronidase inhibitor
0,193  0,028  Alkylator
0,189  0,024  Aminopeptidase B inhibitor
0,179  0,015  Sphingosine 1-phosphate receptor 2 antagonist
0,176  0,014  Actinic keratosis treatment
0,265  0,103  Interleukin 2 agonist
0,168  0,006  Estrogen receptor beta agonist
0,185  0,025  Antiviral (Poxvirus)
0,258  0,099  Antiischemic
0,172  0,013  Electrolyte absorption antagonist
0,176  0,016  Multidrug resistance-associated protein 1 inhibitor
0,176  0,017  TRPA1 agonist
0,205  0,046  Protein kinase C nu inhibitor
0,166  0,008  Biliverdin reductase inhibitor
0,176  0,018  Papain-like protease (SARS coronavirus) inhibitor
0,164  0,006  GABA aminotransferase inhibitor
0,200  0,042  Cyclooxygenase inhibitor
0,177  0,020  Potassium channel (Ca-activated) activator
0,163  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,176  0,019  Photosensitizer
0,166  0,009  Glutathione S-transferase inhibitor
0,169  0,013  Toll-Like receptor 4 antagonist
0,200  0,044  Antineoplastic (carcinoma)
0,182  0,026  Antineoplastic antimetabolite
0,161  0,006  Purinergic P2X1 antagonist
0,162  0,006  Antidote, heavy metal
0,164  0,008  Carbonic anhydrase VA inhibitor
0,172  0,017  DNA repair enzyme inhibitor
0,176  0,022  Alcohol dehydrogenase substrate
0,157  0,004  GABA B receptor agonist
0,190  0,037  Hemostatic
0,163  0,010  Paget's disease treatment
0,157  0,005  Maillard reaction inhibitor
0,232  0,080  Dyrk kinase inhibitor
0,156  0,004  Estrogen-related receptor beta agonist
0,171  0,019  Antineoplastic (uterine cancer)
0,187  0,036  Raynaud's phenomenon treatment
0,205  0,053  Muscle relaxant
0,172  0,021  Contraceptive female
0,186  0,036  Toll-Like receptor antagonist
0,189  0,039  Aldose reductase substrate
0,239  0,090  Antiprotozoal (Trypanosoma)
0,163  0,014  Thioredoxin inhibitor
0,179  0,030  Retinoprotector
0,171  0,023  Interleukin 8 antagonist
0,153  0,005  Plasminogen activator inhibitor antagonist
0,174  0,026  Falcipain 3 inhibitor
0,173  0,025  Anticataract
0,178  0,030  Antiprotozoal (Trichomonas)
0,190  0,044  MAO inhibitor
0,193  0,048  Toxic, respiratory center
0,160  0,014  Dopamine agonist
0,159  0,014  Anabolic
0,176  0,031  Farnesoid X receptor antagonist
0,167  0,022  Catalase inhibitor
0,155  0,011  Argininosuccinate synthase inhibitor
0,148  0,004  Aconitate hydratase inhibitor
0,164  0,020  AMP-activated protein kinase stimulant
0,150  0,007  Glycine receptor agonist
0,146  0,002  Sodium-dependent vitamin C transporter 2 inhibitor
0,192  0,049  Muscular dystrophy treatment
0,152  0,009  Glutamate release inhibitor
0,150  0,008  ATPase (Vacuolar H+) inhibitor
0,155  0,013  Antiviral (Coronavirus)
0,155  0,013  Antiviral (SARS coronavirus)
0,145  0,003  Antidote, organophosphates
0,157  0,016  Antiprotozoal (Toxoplasma)
0,203  0,062  P-glycoprotein inhibitor
0,206  0,066  I kappa B kinase epsilon inhibitor
0,147  0,007  Xanthine dehydrogenase inhibitor
0,195  0,056  Antineoplastic (gastric cancer)
0,213  0,074  MAP kinase kinase 2 inhibitor
0,143  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,147  0,009  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,147  0,009  Acyl-CoA dehydrogenase inhibitor
0,149  0,011  Restless leg syndrome treatment
0,222  0,086  Neuropeptide Y2 antagonist
0,139  0,003  SULT2A1 substrate
0,160  0,024  Mediator release inhibitor
0,166  0,030  Pregnane X receptor agonist
0,149  0,014  HIV-1 reverse transcriptase inhibitor
0,146  0,011  Phosphodiesterase 6D inhibitor
0,154  0,020  Transcription factor STAT6 inhibitor
0,181  0,047  Insulin secretagoues
0,147  0,015  Adrenaline agonist
0,137  0,005  Estrogen receptor alpha agonist
0,164  0,032  Beta amyloid protein antagonist
0,201  0,072  Sedative
0,137  0,008  Narcotic antagonist
0,156  0,027  Antiviral (Papilloma)
0,140  0,012  Lipase inhibitor
0,140  0,011  Thioredoxin reductase inhibitor
0,133  0,004  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,163  0,035  Antiprotozoal (Amoeba)
0,136  0,009  Protein kinase C eta inhibitor
0,130  0,003  Dopamine beta hydroxylase inhibitor
0,163  0,038  Cathepsin H inhibitor
0,129  0,004  Squalene epoxidase inhibitor
0,219  0,095  Calpain inhibitor
0,132  0,008  Neuraminidase inhibitor
0,180  0,056  Antiviral (Hepatitis C)
0,128  0,004  Sphingosine kinase 2 inhibitor
0,178  0,055  Phospholipase A2 inhibitor
0,135  0,014  Antifungal (Aspergillus)
0,139  0,018  Transcription factor NF kappa B stimulant
0,135  0,015  Aminopeptidase I inhibitor
0,137  0,017  Lanosterol 14 alpha demethylase inhibitor
0,146  0,026  Sphingomyelinase inhibitor
0,174  0,055  Acetylcholine M1 receptor antagonist
0,188  0,069  Antiviral (Hepatitis)
0,123  0,006  Fatty acid synthase inhibitor
0,141  0,025  Androgen antagonist
0,119  0,004  Anesthetic inhalation
0,168  0,053  Anesthetic
0,156  0,042  Antitussive
0,135  0,021  Histamine N-methyltransferase inhibitor
0,118  0,005  Glutamate (mGluR7) antagonist
0,119  0,006  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,136  0,023  MAP kinase kinase 1 inhibitor
0,129  0,016  Estrogen receptor alpha antagonist
0,156  0,043  Proteasome inhibitor
0,120  0,008  Endocannabinoid uptake inhibitor
0,126  0,015  Glycine receptor antagonist
0,159  0,048  Cocaine dependence treatment
0,210  0,098  Antineoplastic (liver cancer)
0,116  0,005  MAP kinase kinase 7 inhibitor
0,144  0,034  Bronchodilator
0,113  0,004  DNA helicase inhibitor
0,123  0,015  Leukotriene synthesis inhibitor
0,149  0,041  MAO A inhibitor
0,145  0,038  Sphingosine 1-phosphate receptor 4 antagonist
0,117  0,009  CC chemokine 5 receptor agonist
0,118  0,011  CDC25B inhibitor
0,111  0,005  Glucose-6-phosphate translocase inhibitor
0,115  0,008  Antimycoplasmal
0,127  0,021  Ornithine decarboxylase inhibitor
0,160  0,054  MAP kinase 3 inhibitor
0,109  0,004  Glucose-6-phosphate isomerase inhibitor
0,137  0,032  Antineoplastic alkaloid
0,217  0,113  Antituberculosic
0,133  0,029  Protein kinase A inhibitor
0,134  0,030  Acetylcholine release stimulant
0,140  0,036  Caspase 3 inhibitor
0,121  0,018  Bile acid receptor antagonist
0,111  0,008  Heat shock protein 90 beta antagonist
0,158  0,055  Hearing loss treatment
0,142  0,040  MAO B inhibitor
0,114  0,012  Anticholelithogenic
0,124  0,023  Inducible nitric-oxide synthase inhibitor
0,106  0,006  Sphingosine kinase inhibitor
0,112  0,012  Beta 3 adrenoreceptor antagonist
0,110  0,010  Antitreponemal
0,104  0,004  Dihydroorotate oxidase inhibitor
0,108  0,008  Glutamate (mGluR6) antagonist
0,110  0,010  Protein kinase C beta inhibitor
0,104  0,005  Vanilloid 2 antagonist
0,114  0,015  Postmenopausal disorders treatment
0,108  0,009  Carbonic anhydrase XIV inhibitor
0,108  0,010  Dopamine D2 agonist
0,139  0,041  Shock treatment
0,117  0,019  Histone deacetylase stimulant
0,117  0,019  Histone deacetylase SIRT1 stimulant
0,107  0,010  Estradiol 17 beta-dehydrogenase inhibitor
0,116  0,019  mTOR complex 2 inhibitor
0,147  0,050  Anesthetic local
0,116  0,019  Na+ K+ transporting ATPase inhibitor
0,185  0,089  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,161  0,067  Antianorexic
0,141  0,047  Protein kinase (CK2) alpha inhibitor
0,099  0,006  Postcoital contraceptive
0,096  0,004  Alpha 1d adrenoreceptor agonist
0,224  0,132  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,096  0,005  Ryanodine receptor antagonist
0,112  0,021  Dopamine D1 antagonist
0,147  0,057  Nav1.6 sodium channel blocker
0,128  0,038  Gastric antisecretory
0,104  0,015  Beta adrenoreceptor antagonist
0,097  0,007  Bcl-xL inhibitor
0,092  0,003  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,093  0,005  Adenine nucleotide translocase inhibitor
0,101  0,013  S-adenosyl-L-methionine decarboxylase inhibitor
0,161  0,074  Interleukin 6 antagonist
0,182  0,095  Interleukin antagonist
0,091  0,005  Adenylate cyclase 1 inhibitor
0,149  0,063  Histone deacetylase SIRT1 inhibitor
0,129  0,043  Protein kinase (CK2) inhibitor
0,156  0,070  Acute respiratory distress syndrome (ARDS) treatment
0,112  0,028  Tocolytic
0,117  0,034  Glutamate (mGluR7) agonist
0,120  0,038  Nitric-oxide synthase inhibitor
0,091  0,010  Transcription factor RelA inhibitor
0,111  0,030  CYP2A6 inhibitor
0,141  0,061  Cyclooxygenase 2 inhibitor
0,097  0,016  Phospholipase D inhibitor
0,098  0,018  Vanilloid 4 agonist
0,223  0,143  CYP3A4 inhibitor
0,090  0,011  Carbonic anhydrase VII inhibitor
0,216  0,137  Antimycobacterial
0,122  0,042  Mental retardation treatment
0,097  0,018  NMDA receptor glycine site agonist
0,102  0,024  Sphingosine 1-phosphate receptor 4 agonist
0,134  0,056  CC chemokine 6 receptor antagonist
0,089  0,011  Glutamate (mGluR group III) agonist
0,116  0,039  Interleukin 1 beta converting enzyme inhibitor
0,084  0,007  Beta 2 adrenoreceptor agonist
0,081  0,005  Neuraminidase (Influenza A) inhibitor
0,082  0,006  Pregnane X receptor antagonist
0,085  0,009  Alpha-mannosidase inhibitor
0,090  0,015  Exportin-1 inhibitor
0,083  0,008  Phosphoglycerate kinase inhibitor
0,097  0,022  Aromatase inhibitor
0,244  0,169  Antiprotozoal
0,080  0,007  Fumarate hydratase inhibitor
0,110  0,037  Antiviral (Rhinovirus)
0,076  0,004  Glutamate (mGluR8) agonist
0,093  0,022  NMDA receptor agonist
0,074  0,004  Dopamine D1 agonist
0,089  0,019  Androgen agonist
0,111  0,041  Antineoplastic antibiotic
0,089  0,019  Uterine relaxant
0,078  0,009  Mannosidase inhibitor
0,084  0,015  MDM2 inhibitor
0,073  0,004  Tubulin agonist
0,134  0,066  Acetylcholinesterase inhibitor
0,083  0,016  Beta 1 adrenoreceptor antagonist
0,079  0,012  CD45 antagonist
0,076  0,010  CXC chemokine 1 receptor antagonist
0,143  0,076  Thiol protease inhibitor
0,194  0,128  Lipoprotein disorders treatment
0,085  0,020  Ornithine carbamoyltransferase inhibitor
0,078  0,013  Dopamine D5 antagonist
0,074  0,009  Cholesterol esterase inhibitor
0,096  0,031  Antiviral (Dengue virus)
0,082  0,018  Phosphodiesterase 1C inhibitor
0,091  0,028  Potassium channel large-conductance Ca-activated activator
0,068  0,005  Guanylate cyclase inhibitor
0,076  0,013  Beta 2 adrenoreceptor antagonist
0,097  0,034  Cathepsin G inhibitor
0,073  0,011  Leukotriene C antagonist
0,228  0,165  Calpain 2 inhibitor
0,119  0,057  GABA receptor agonist
0,068  0,007  Sphingosine kinase 1 inhibitor
0,066  0,005  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,100  0,039  Antiviral (Trachoma)
0,065  0,005  Kainate receptor agonist
0,077  0,017  Calcium channel P-type blocker
0,074  0,015  NMDA receptor subunit 3B antagonist
0,103  0,045  NMDA receptor antagonist
0,076  0,018  Glucosylceramidase inhibitor
0,141  0,083  MAP kinase kinase 4 inhibitor
0,126  0,068  MAP kinase kinase inhibitor
0,067  0,009  Geranyltranstransferase inhibitor
0,093  0,035  Interferon agonist
0,081  0,023  Alpha 2 adrenoreceptor agonist
0,070  0,013  Adenosine deaminase inhibitor
0,065  0,008  GABA uptake inhibitor
0,069  0,012  Immunoglobulin Fc receptor antagonist
0,088  0,031  Phosphodiesterase VI inhibitor
0,076  0,019  Botulinum neurotoxin type A inhibitor
0,064  0,007  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,094  0,037  Antibiotic
0,075  0,019  Heme oxygenase stimulant
0,065  0,009  Arginase inhibitor
0,060  0,004  Estrogen-related receptor beta antagonist
0,064  0,008  Nerve growth factor antagonist
0,065  0,010  GABA B receptor antagonist
0,100  0,045  Phosphodiesterase I inhibitor
0,078  0,023  Antihemophilic
0,060  0,005  Uridine phosphorylase inhibitor
0,081  0,026  Ribonucleotide reductase inhibitor
0,065  0,011  Purinergic P2X4 antagonist
0,092  0,038  Caspase 7 inhibitor
0,079  0,025  Ribonucleoside-diphosphate reductase inhibitor
0,103  0,049  Interleukin 12 antagonist
0,138  0,085  Neuropeptide Y1 antagonist
0,090  0,037  NMDA 2 receptor antagonist
0,102  0,049  Antifungal (Candida)
0,105  0,051  Tourette's syndrome treatment
0,059  0,006  Nucleoside transporters inhibitor
0,101  0,048  ABCA1 expression enhancer
0,244  0,191  Transcription factor inhibitor
0,139  0,086  Diuretic
0,064  0,011  Liver X receptor alpha agonist
0,079  0,026  NMDA 2C receptor antagonist
0,058  0,005  GABA transporter 3 inhibitor
0,080  0,027  5 Hydroxytryptamine 3 agonist
0,075  0,023  Cyclin D1 inhibitor
0,070  0,018  Lysine-specific demethylase 1A inhibitor
0,057  0,005  CF transmembrane conductance regulator antagonist
0,057  0,005  ATP citrate lysase inhibitor
0,086  0,034  Alpha adrenoreceptor agonist
0,148  0,097  Antipruritic
0,130  0,079  Psychosexual dysfunction treatment
0,079  0,028  Aryl hydrocarbon receptor antagonist
0,075  0,025  Transcription factor AP-1 inhibitor
0,067  0,017  Lysophosphatidic acid 3 receptor antagonist
0,079  0,029  Gaucher disease treatment
0,106  0,055  Antischistosomal
0,061  0,011  Dihydropteroate synthase inhibitor
0,064  0,014  Dihydroorotase inhibitor
0,077  0,027  Carbonic anhydrase stimulant
0,052  0,003  Estrogen-related receptor gamma antagonist
0,076  0,028  Interferon inducer
0,083  0,035  Amidase inhibitor
0,142  0,094  Growth hormone agonist
0,066  0,019  Prolyl endopeptidase inhibitor
0,062  0,015  Oxytocin agonist
0,053  0,007  Vanilloid 3 antagonist
0,067  0,021  Leukotriene B4 antagonist
0,056  0,011  Beta adrenoreceptor agonist
0,078  0,033  Hyperparathyroidism treatment
0,110  0,066  Alpha 2b adrenoreceptor antagonist
0,076  0,032  Potassium channel (ATP-sensitive) blocker
0,079  0,035  Carbonic anhydrase inhibitor
0,049  0,005  Glutamate (mGluR3) agonist
0,116  0,072  Retinopathy treatment
0,196  0,152  CYP2D6 inhibitor
0,078  0,034  Bcl2 antagonist
0,060  0,017  NMDA receptor subunit 3A antagonist
0,187  0,144  Amyotrophic lateral sclerosis treatment
0,078  0,036  Acetylcholine M5 receptor agonist
0,092  0,049  Antileprosy
0,053  0,011  Glutamate (mGluR3) antagonist
0,053  0,010  Heme oxygenase inhibitor
0,052  0,010  Glucose-6-phosphate dehydrogenase inhibitor
0,049  0,007  Protein kinase (CK2) beta inhibitor
0,076  0,035  Leukotriene antagonist
0,064  0,023  Epithelial sodium channel blocker
0,091  0,050  Bcr-Abl kinase inhibitor
0,044  0,004  Alpha 2a adrenoreceptor agonist
0,130  0,090  Corneal wound healing stimulator
0,049  0,010  Cholesterol absorption inhibitor
0,097  0,058  Breast cancer-resistant protein inhibitor
0,189  0,150  Antineoplastic (bladder cancer)
0,088  0,049  3C-Like protease (SARS coronavirus) inhibitor
0,100  0,061  Dementia treatment
0,062  0,024  Nicotinic alpha3beta2 receptor antagonist
0,059  0,021  Potassium channel Kv1.3 blocker
0,064  0,027  NMDA 2A receptor antagonist
0,112  0,075  Acetylcholine muscarinic antagonist
0,077  0,040  Secretase beta inhibitor
0,067  0,030  Carbonic anhydrase XII inhibitor
0,117  0,081  M17 leucyl aminopeptidase inhibitor
0,071  0,035  Protease 3C (Human rhinovirus) inhibitor
0,097  0,060  Vascular dementia treatment
0,048  0,012  Leukotriene C4 antagonist
0,083  0,047  Nicotinic alpha4beta2 receptor antagonist
0,066  0,030  Sphingosine 1-phosphate receptor 3 antagonist
0,108  0,073  Myasthenia Gravis treatment
0,040  0,004  Vanilloid 2 agonist
0,045  0,009  Tryptophan 5 hydroxylase inhibitor
0,084  0,049  Metalloproteinase-2 inhibitor
0,040  0,005  Glutamate (mGluR1a) agonist
0,038  0,003  Vesicular glutamate transport inhibitor
0,045  0,010  Lysophosphatidic acid 2 receptor antagonist
0,061  0,026  Thromboxane synthase inhibitor
0,052  0,018  Glutamate (mGluR group III) antagonist
0,040  0,007  Purinergic P2Y15 antagonist
0,052  0,019  Glutamate (mGluR4) antagonist
0,040  0,006  Thyroid hormone agonist
0,058  0,026  Heparanase inhibitor
0,057  0,024  Antiviral (Herpesvirus 3, Human)
0,052  0,020  AICAR transformylase inhibitor
0,083  0,051  Sleep apnea treatment
0,037  0,005  Hedgehog signaling activator
0,040  0,008  Sodium/glucose cotransporter 2 inhibitor
0,069  0,038  5 Hydroxytryptamine 2A agonist
0,047  0,016  Nicotinic acid receptor agonist
0,044  0,013  Free fatty acid receptor 1 antagonist
0,083  0,052  Xanthine oxidase substrate
0,089  0,058  Bromodomain-containing protein 2 inhibitor
0,034  0,004  Nicotinic acid receptor 1 antagonist
0,046  0,016  Retinoid X receptor antagonist
0,036  0,006  Prostaglandin F2 alpha agonist
0,033  0,003  Glutamate (mGluR6) agonist
0,049  0,020  Thymidine kinase inhibitor
0,054  0,025  Factor III inhibitor
0,035  0,006  GRP78 expression inhibitor
0,065  0,036  Phosphodiesterase 1B inhibitor
0,097  0,068  Alpha 2c adrenoreceptor antagonist
0,108  0,079  Menstruation disorders treatment
0,036  0,008  Sodium/glucose cotransporter inhibitor
0,032  0,004  Estrogen-related receptor gamma agonist
0,042  0,014  Ceramide glucosyltransferase inhibitor
0,052  0,024  Cytokine production stimulant
0,055  0,027  Potassium channel (Inward rectifier) activator
0,051  0,024  Fructose-1,6-bisphosphatase inhibitor
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,093  0,065  Posttraumatic stress disorder treatment
0,035  0,008  Sodium/glucose cotransporter 1 inhibitor
0,063  0,036  Potassium channel intermediate-conductance Ca-activated blocker
0,040  0,013  Liver X receptor beta antagonist
0,061  0,034  Carbonic anhydrase II inhibitor
0,077  0,051  Alpha 2a adrenoreceptor antagonist
0,051  0,024  Carbonic anhydrase IV inhibitor
0,061  0,035  Carbonic anhydrase I inhibitor
0,075  0,049  Potassium channel (Tandem pore domain) blocker
0,052  0,026  Potassium channel (ATP-sensitive) activator
0,043  0,017  Retinoid X alpha receptor agonist
0,089  0,063  Polo-like kinase-1 inhibitor
0,029  0,004  Antibiotic Anthracycline-like
0,061  0,037  Carbonic anhydrase IX inhibitor
0,046  0,021  Urate transporter 1 inhibitor
0,034  0,010  CXC chemokine 2 receptor antagonist
0,058  0,034  5 Hydroxytryptamine 7 agonist
0,060  0,036  Lipocortins synthesis agonist
0,108  0,085  Growth stimulant
0,253  0,230  MAP kinase 1 inhibitor
0,073  0,050  Metalloproteinase-9 inhibitor
0,070  0,048  Prostaglandin-E synthase inhibitor
0,052  0,029  Phosphorylase inhibitor
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,041  0,019  Delayed rectifier potassium channel blocker
0,055  0,033  Dihydroorotate dehydrogenase inhibitor
0,208  0,186  Antiprotozoal (Plasmodium)
0,039  0,017  Retinoid X alpha receptor antagonist
0,068  0,046  Andropause treatment
0,026  0,004  Telomerase stimulant
0,042  0,021  Retinoid X receptor agonist
0,035  0,014  Hypoxanthine phosphoribosyltransferase inhibitor
0,024  0,003  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,132  0,111  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,043  0,022  Membrane dipeptidase inhibitor
0,112  0,091  Antismoking
0,081  0,061  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,060  0,040  Phosphodiesterase 1A inhibitor
0,135  0,115  LIM domain kinase 1 inhibitor
0,127  0,107  Cyclin-dependent kinase 8 inhibitor
0,025  0,006  Ileal bile acid transport inhibitor
0,045  0,026  Dihydrofolate reductase inhibitor
0,029  0,010  Complement factor 1s inhibitor
0,042  0,023  AMPA 4 receptor antagonist
0,051  0,032  HCV NS3/NS4A protease inhibitor
0,080  0,061  Antiprotozoal activity enhancer
0,030  0,011  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,034  0,016  Nicotinic alpha3beta4 receptor agonist
0,044  0,026  Histone deacetylase 8 inhibitor
0,035  0,017  Protein kinase C beta II inhibitor
0,048  0,030  Thymidylate synthase inhibitor
0,025  0,007  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,061  0,044  Corticotropin releasing factor 2 receptor antagonist
0,028  0,011  Glutamate (mGluR1) agonist
0,085  0,068  Potassium channel activator
0,029  0,012  Thymidine phosphorylase inhibitor
0,052  0,035  Thromboxane A2 antagonist
0,063  0,047  Neutrophil collagenase inhibitor
0,095  0,078  HDL-cholesterol increasing
0,030  0,013  Prostaglandin H2 antagonist
0,025  0,009  Vesicular acetylcholine transporter inhibitor
0,036  0,020  Sirtuin 2 inhibitor
0,044  0,029  Histamine H1 receptor agonist
0,081  0,065  Insulin growth factor antagonist
0,130  0,115  Liver fibrosis treatment
0,053  0,038  Thromboxane antagonist
0,111  0,096  Toll-Like receptor 9 antagonist
0,035  0,021  Glutamate (mGluR4) agonist
0,033  0,018  AMPA 3 receptor antagonist
0,080  0,066  Alpha 2 adrenoreceptor antagonist
0,039  0,025  Diamine oxidase inhibitor
0,030  0,016  Lysine carboxypeptidase inhibitor
0,079  0,065  Calcium antagonist
0,022  0,008  Alpha 2b adrenoreceptor agonist
0,039  0,025  Farnesoid X receptor agonist
0,023  0,010  Neuraminidase (Influenza B) inhibitor
0,020  0,006  Thromboxane A2 agonist
0,031  0,017  Liver X receptor alpha antagonist
0,027  0,014  Lysophosphatidic acid receptor 1 agonist
0,026  0,013  Fructose-1,6-bisphosphatase 1 inhibitor
0,025  0,012  Beta 1 adrenoreceptor agonist
0,020  0,007  NMDA receptor phencyclidine site antagonist
0,038  0,026  Potassium channel Kv1.1 blocker
0,021  0,008  Methylmalonyl-CoA mutase inhibitor
0,079  0,067  Histamine H2 receptor antagonist
0,031  0,019  GABA transporter 2 inhibitor
0,014  0,002  Insulin like growth factor 3 antagonist
0,069  0,057  Peroxisome proliferator-activated receptor gamma antagonist
0,125  0,113  Antifungal (Cryptococcus)
0,032  0,021  Cholesterol ester transfer protein antagonist
0,070  0,058  Adenosine A3 receptor antagonist
0,057  0,046  Acetylcholine M5 receptor antagonist
0,107  0,096  Glycogen synthase kinase-3 alpha inhibitor
0,018  0,008  Purinergic P2Y1 agonist
0,023  0,012  GABA transporter inhibitor
0,022  0,011  Retinoid X beta receptor antagonist
0,019  0,008  Thyroid hormone alpha agonist
0,062  0,052  Matrix metalloproteinase inhibitor
0,045  0,035  Antimetabolite
0,060  0,050  Histone deacetylase SIRT3 inhibitor
0,038  0,029  Histone deacetylase 9 inhibitor
0,036  0,027  Integrin alpha2 antagonist
0,047  0,038  Bombesin 2 receptor antagonist
0,034  0,025  RNA-directed RNA polymerase inhibitor
0,136  0,128  Lipocortins synthesis antagonist
0,018  0,009  Thyroid hormone alpha antagonist
0,018  0,010  Carbonic anhydrase X inhibitor
0,018  0,010  Carbonic anhydrase VIII inhibitor
0,140  0,132  Catenin beta inhibitor
0,041  0,033  Histamine H2 receptor agonist
0,020  0,013  Antibiotic Quinolone-like
0,032  0,025  Melatonin receptor 1A agonist
0,032  0,025  Liver X receptor beta agonist
0,077  0,070  GABA A receptor agonist
0,097  0,090  Electron transport complex I inhibitor
0,026  0,019  Integrin alpha2beta1 antagonist
0,016  0,009  Antibiotic Tetracycline-like
0,028  0,021  Nicotinic alpha4beta2 receptor agonist
0,023  0,016  ICAM 1 antagonist
0,099  0,093  Autism spectrum disorders treatment
0,020  0,014  Imidazoline I1 receptor antagonist
0,014  0,009  Lysophosphatidic acid receptor 3 agonist
0,055  0,050  Opioid delta receptor antagonist
0,034  0,029  5-Alpha-reductase inhibitor
0,054  0,049  Acetylcholine M3 receptor antagonist
0,029  0,024  Prostaglandin agonist
0,009  0,004  DNA topoisomerase III inhibitor
0,046  0,041  Matrix metalloproteinase 1 inhibitor
0,039  0,034  Leukocyte elastase inhibitor
0,009  0,005  Thyroid hormone beta agonist
0,096  0,092  Nav1.5 sodium channel blocker
0,029  0,025  HCV NS5B polymerase inhibitor
0,012  0,008  Egl nine homolog 3 inhibitor
0,010  0,006  Progesterone receptor A antagonist
0,011  0,007  Thromboxane agonist
0,037  0,033  5 Hydroxytryptamine 2B agonist
0,055  0,051  TRPA1 antagonist
0,181  0,178  Thyroid hormone antagonist
0,043  0,040  Aldosterone antagonist
0,032  0,029  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,028  0,025  Liver X receptor antagonist
0,033  0,030  Histone deacetylase 7 inhibitor
0,062  0,059  Elastase 1 inhibitor
0,017  0,015  Alpha 2c adrenoreceptor agonist
0,105  0,103  Nav1.2 sodium channel blocker
0,073  0,071  Opioid kappa receptor antagonist
0,024  0,022  Kynurenine 3 monooxygenase inhibitor
0,144  0,143  Hypolipemic
0,022  0,020  NMDA receptor glycine site antagonist
0,014  0,012  Egl nine homolog 1 inhibitor
0,035  0,034  Toll-Like receptor 2 agonist
0,029  0,028  Calcitonin receptor agonist
0,051  0,050  Alpha 1 adrenoreceptor agonist
0,031  0,030  Kainate receptor 2 antagonist
0,010  0,009  Purinergic P2Y2 agonist
0,024  0,023  Acid ceramidase inhibitor
0,049  0,048  Matrix metalloproteinase (membrane-type) inhibitor
0,029  0,028  Methionyl aminopeptidase 1 inhibitor
0,005  0,005  Transcortin receptor antagonist
0,017  0,016  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor

